Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DR26F1J02
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $79,716
Award facts
- Contract value 100% obligated
- $79,715.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $79,715.69 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, issued on November 18, 2025, with an ultimate completion date of November 19, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through December 2026). The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with the place of performance located at the company's Conshohocken facility.
Repatha (evolocumab) is a PCSK9 inhibitor used for cholesterol management and cardiovascular disease prevention, supplied through the company's comprehensive pharmaceutical supply agreement with DLA. As a major pharmaceutical distributor to military and veteran healthcare systems, AmerisourceBergen fulfills a wide range of federal medical supply needs, from specialty medications to vaccines and medical devices. This delivery order reflects the company's ongoing role in supporting the Defense Health Agency and other government healthcare systems through DLA's pharmaceutical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26F1J02?
SPE2DR26F1J02 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26F1J02 worth?
The government has obligated $79,716 on SPE2DR26F1J02.
Is contract SPE2DR26F1J02 an order under another contract?
Yes. SPE2DR26F1J02 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1J02 competed?
The extent of competition for SPE2DR26F1J02 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award